Astrazeneca Ab

Johan Rune Michael Lundkvist

Stephen Connolly

Martin Hemmerling

Nafizal Hossain

Grigorios Nikitidis

Lena Elisabeth Ripa

Igor Shamovsky

Anna Kristoffersson

Susanne Elisabeth Berglund

The present invention provides a compound of a formula (I): or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an ENaC mediated disease state (such as asthma, CF or COPD).

Chemical compounds

The present invention provides a compound of a formula (I): 

The present invention provides a compound of a formula (I): or a pharmaceutically acceptable salt thereof; a process for preparing such a compound; and to the use of such a compound in the treatment of an ENaC mediated disease state (such as asthma, CF or COPD). 

Growing community of inventors

Macclesfield, United Kingdom

Johan Rune Michael Lundkvist